• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/41

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

41 Cards in this Set

  • Front
  • Back
brompheniramine
first gen H1 blocker, anticholinergic activity
IN GENERAL of 1st gen H1 blockers:
rapidly absorbed when taken orally
distributes to most tissues
4-6 hrs duration of action
clinical use: allergic reactions - hay fever, urticaria, not utilized for bronchial asthma
motion sickness- prevention rather than tx, sedative effects, diphenhydramine>cyclizine and meclizine
local anesthetic action - Na channel blockers, diphenhydramine and promethazine are more potent than procaine as local anesthetics
others: antiparkinsonian, anticholinergic, adrenergic-blocking, serotonin-blocking
side effects: slight sedation, anti-muscarinic - urinary retention, blurred vision
interactions: cyp450 inhibition (antifungals), think about sedation when giving other CNS depressants
chlorpheniramine
first gen H1 blocker, anticholinergic activity
side effects: slight sedation, common component of OTC cold meds
clemastine
first gen H1 blocker
cyclizine
first gen H1 blocker, anticholinergic activity
side effects: slight sedation
effects: anti-motion sickness activity
cypropheptadine
first gen H1 blocker
dexchlorpheniramine
first gen H1 blocker
dimenhydrinate
first gen H1 blocker, anticholinergic activity
side effects: marked sedation
effects: anti-motion sickness activity
diphenhydramine
first gen H1 blocker
hydroxyzine
first gen H1 blocker
meclizine
first gen H1 blocker
promethazine
first generation H1 blocker, anticholinergic activity;
marked sedation, antiemetic, block
cetirizine
2nd generation H1 blocker, no anticholinergic effects
in general:
12-24 hours duration of action
effects:
allergic reactions - allergic rhinitis and urticaria, not utilized for bronchial asthma
motion sickness - prevention rather than treatment, sedative effects: diphenhydramine > cyclizine and meclizine
local anesthetic action - Na channel blockers, diphenhydramine and prometazine are more potent than procaine as local anesthetics
other effects: antiparkinsonian, anticholinergic, adrenergic blocking, serotonin blocking
toxicity: sedation
drug interactions: cyp450 inhibition (anti-fungals), sedation effect - addnl consideration when given w/ other CNS depressants
desloratadine
2nd generation H1 blocker, no anticholinergic effects
fexofenadine
2nd generation H1 blocker, no anticholinergic effects
loratadine
2nd generation H1 blocker, no anticholinergic effects
longer action
azelastine
2nd generation H1 blocker, no anticholinergic effects
cimetidine
H2 blockers
effects: reducing gastric acid secretion - peptic ulcer, GERD, other hypersecretory diseases
little effect on cardiac fxn, intestinal secretion
famotidine
H2 blockers
effects: reducing gastric acid secretion - peptic ulcer, GERD, other hypersecretory diseases
little effect on cardiac fxn, intestinal secretion
nizatidine
H2 blockers
effects: reducing gastric acid secretion - peptic ulcer, GERD, other hypersecretory diseases
little effect on cardiac fxn, intestinal secretion
ranitidine
H2 blockers
effects: reducing gastric acid secretion - peptic ulcer, GERD, other hypersecretory diseases
little effect on cardiac fxn, intestinal secretion
cromolyn
histamine release inhibitors
nedocromil
histamine release inhibitors
buspirone
5-HT receptor agonist
5-HT1A partial agonist
non-benzodiazepine anxiolytic
fenfluramine
5-HT receptor agonist
5-HT4 agonist
dexfenfluramine
5-HT receptor agonist
5-HT4 agonist
5-HT2C agonist - appetite suppression, withdrawn due to toxicity
cisapride
5-HT receptor agonist
5-HT4 agonist
used for the treatment of GERD and motility disorders
available for compassionate use
almotriptan
selective 5-HT1D and 5-HT1B receptor agonists
other -triptans as well!!!
effects:
counteracts vasodilating peptide calcitonin gene-related peptide (CGRP)
constrict cerebral and meningeal vessels in tx acute migraines
efficacy aginst migraine similar to other classes of drugs
side effects: tingling and warmth sensations, dizziness, muscle weakness, neck pain, chest discomfort (vasospasm, angina)
phenoxybenzamine
non-selective 5-HT antagonists
5-HT2 antagonist - long acting!! (irreversible (and alpha-adrenergic receptors)
cyproheptadine
5-HT2 antagonist and H1 receptor antagonist
useful for the smooth muscle effects of carcinoid tumors
serotonin syndrome treatment
ondansetron
5-HT3 receptor antagonists
other -setrons as well!
used for treatment of nausea/vomiting in cancer chemo
dihydroergotamine
nonselective 5-HT agonists
limited 5-HT effects
preferred for the treatment of migraine
side effects IN GENERAL:
nausea, vomiting, diarrhea due to increased GIT motility resulting from activation of 5-HT receptors in the CNS and GIT
most serious toxic effect - prolonged vasospasm in the arms/legs, may cause gangrene and amputation
drowsiness and hallucinations occur infrequently
ergonovine
nonselective 5-HT agonists
most selective for the uterus, if oxytocin fails, is utilized to limit post-partum hemorrhage
ergotamine mixtures
nonselective 5-HT agonists
ergotamine tartrate
nonselective 5-HT agonists
methylergonovine
nonselective 5-HT agonists
lysergic acid diethylamine (LSD)
nonselective 5-HT agonists
powerful hallucinogen
ergotamine
nonselective 5-HT agonists
potent vasoconstrictor
ergocryptime
nonselective 5-HT agonists
bromocriptine
nonselective 5-HT agonists
in general:
agonists, partial agonists, and antagonists at diverse receptors - alpha adrenergic receptors, 5-HT1A and ID > 5-HT2 and HT3, central dopamine receptors
act at both pre and post-synaptic sites
effects:
CNS - selectivity for pituitary dopamine receptors, suppress prolactin secretion, useful in tx pit tumor
cabergoline
nonselective 5-HT agonists
effects:
selective for pituitary dopamine receptors, suppress prolactin secretion, useful in tx pituitary tumor
tegaserod
partial 5-HT4 agonist
utilized for IBS with constipation